Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Planned sale SVP, Chief Commercial Officer sold 10,417 shares at $28.10 ($292,740)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 2,845 shares (to pay taxes)
  11. 4 Open-market sale VP, Finance (Interim PAO) sold 2,559 shares at $29.65 ($75,874)
  12. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 2,587 shares (to pay taxes)
  13. 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 3,414 shares (to pay taxes)
  14. 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 1,811 shares (to pay taxes)
  15. 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 3,880 shares (to pay taxes)
  16. 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 3,414 shares (to pay taxes)
  17. 4 Derivatives Options or other derivatives
  18. 4 Shares withheld for taxes VP, Finance (Interim PAO) gave up 908 shares (to pay taxes)
  19. 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 3,156 shares (to pay taxes)
  20. 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 1,929 shares (to pay taxes)

Page 8 of 67 · 1,323 filings